Ha habido 50 transacciones internas recientes registradas para Cogent Biosciences, Inc. (COGT), incluyendo 41 compras y 9 ventas. El total de compras internas fue valorado en $64.89M y el total de ventas internas en $139.58M.
Internos destacados con actividad reciente incluyen Ferrante Karen Jean, Fairmount Funds Management Llc, Green John L.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — COGT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
686 |
$35.24 |
$24.17K |
686 |
| 2026-03-31 |
Fairmount Funds Management Llc |
Director |
Conversión (Venta) |
28,000 |
- |
- |
39,414 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
Venta Informativa |
3,500,000 |
$36.40 |
$127.4M |
5,503,418 |
| 2026-01-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
643 |
$34.74 |
$22.34K |
643 |
| 2025-12-26 |
Green John L. |
Chief Financial Officer |
Venta Informativa |
77,000 |
$38.68 |
$2.98M |
131,834 |
| 2025-12-26 |
Kearns Evan |
Chief Legal Officer |
Venta Informativa |
65,000 |
$38.70 |
$2.52M |
109,398 |
| 2025-12-26 |
Sachs Jessica |
Chief Medical Officer |
Venta Informativa |
82,642 |
$38.70 |
$3.2M |
133,938 |
| 2025-12-26 |
Robinson John Edward |
Chief Scientific Officer |
Venta Informativa |
90,000 |
$38.74 |
$3.49M |
140,002 |
| 2025-12-17 |
Robbins Andrew R |
President and CEO |
Concesión de RSU |
185,000 |
- |
- |
185,000 |
| 2025-12-17 |
Green John L. |
Chief Financial Officer |
Concesión de RSU |
50,000 |
- |
- |
53,841 |
| 2025-12-17 |
Kearns Evan |
Chief Legal Officer |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2025-12-17 |
Sachs Jessica |
Chief Medical Officer |
Concesión de RSU |
50,000 |
- |
- |
51,296 |
| 2025-12-17 |
Robinson John Edward |
Chief Scientific Officer |
Concesión de RSU |
50,000 |
- |
- |
50,000 |
| 2025-12-17 |
Pinnow Cole |
Chief Commercial Officer |
Concesión de RSU |
65,000 |
$39.45 |
$2.56M |
65,000 |
| 2025-10-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
1,642 |
$14.13 |
$23.2K |
1,642 |
| 2025-07-10 |
Fairmount Funds Management Llc |
Director |
Compra Informativa |
2,777,777 |
$9.00 |
$25M |
9,003,418 |
| 2025-07-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
3,314 |
$7.22 |
$23.93K |
3,314 |
| 2025-06-04 |
Morris Arlene |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Harwin Peter Evan |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Ros Matthew |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Shegog Todd |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-06-04 |
Cain Christopher W. |
Director |
Concesión de RSU |
44,700 |
$5.64 |
$252.11K |
44,700 |
| 2025-04-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
3,788 |
$5.79 |
$21.93K |
3,788 |
| 2025-01-23 |
Robbins Andrew R |
President and CEO |
Concesión de RSU |
915,000 |
$8.89 |
$8.13M |
915,000 |
| 2025-01-23 |
Green John L. |
Chief Financial Officer |
Concesión de RSU |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Kearns Evan |
Chief Legal Officer |
Concesión de RSU |
230,000 |
$8.89 |
$2.04M |
230,000 |
| 2025-01-23 |
Sachs Jessica |
Chief Medical Officer |
Concesión de RSU |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Robinson John Edward |
Chief Scientific Officer |
Concesión de RSU |
270,000 |
$8.89 |
$2.4M |
270,000 |
| 2025-01-23 |
Pinnow Cole |
Chief Commercial Officer |
Concesión de RSU |
240,000 |
$8.89 |
$2.13M |
240,000 |
| 2025-01-14 |
Pinnow Cole |
Chief Commercial Officer |
Compra Informativa |
43,750 |
$7.60 |
$332.41K |
45,848 |
| 2025-01-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
2,785 |
$7.80 |
$21.72K |
2,785 |
| 2024-10-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
2,034 |
$10.75 |
$21.87K |
2,034 |
| 2024-07-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
2,462 |
$8.94 |
$22.01K |
2,462 |
| 2024-06-10 |
Fairmount Funds Management Llc |
Director |
Ejercicio de Opciones (Venta) |
1,500 |
- |
- |
- |
| 2024-06-05 |
Morris Arlene |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Harwin Peter Evan |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Ros Matthew |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Shegog Todd |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-06-05 |
Cain Christopher W. |
Director |
Concesión de RSU |
44,700 |
$8.92 |
$398.72K |
44,700 |
| 2024-05-25 |
Pinnow Cole |
Chief Commercial Officer |
Disposición |
- |
- |
- |
700 |
| 2024-05-25 |
Pinnow Cole |
Chief Commercial Officer |
Concesión de RSU |
525,000 |
$8.22 |
$4.32M |
525,000 |
| 2024-04-01 |
Ferrante Karen Jean |
Director |
Concesión de RSU |
3,213 |
$6.90 |
$22.17K |
3,213 |
| 2024-03-28 |
Fairmount Funds Management Llc |
Director |
Otro (Venta) |
11,914 |
- |
- |
- |
| 2024-02-16 |
Fairmount Funds Management Llc |
10 Percent Owner |
Concesión de RSU |
1,500 |
- |
- |
1,500 |
| 2024-01-23 |
Robbins Andrew R |
President and CEO |
Concesión de RSU |
1,100,000 |
$4.63 |
$5.09M |
1,100,000 |
| 2024-01-23 |
Green John L. |
Chief Financial Officer |
Concesión de RSU |
300,000 |
$4.63 |
$1.39M |
300,000 |
| 2024-01-23 |
Kearns Evan |
Chief Legal Officer |
Concesión de RSU |
255,000 |
$4.63 |
$1.18M |
255,000 |
| 2024-01-23 |
Sachs Jessica |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$4.63 |
$1.39M |
300,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
